Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23Months at Increased Risk for Meningococcal Disease: Recommendationsof the Advisory Committee on Immunization Practices, 2013
Jessica R. MacNeil, MPH1, Lorry Rubin, MD2, Lucy McNamara, PhD3, Elizabeth C. Briere, MD1, Thomas A.
Media Type: Html
- SourceUrl: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6324a2.htm
- Syndication ID: 1200
- Language: English
- Source: Centers for Disease Control and Prevention (CDC)
- Date Syndication Captured: Thursday, June 19, 2014 at 07:10 PM
- Date Syndication Updated: Monday, May 23, 2016 at 11:42 PM
Tags
General:
children
disease
vaccine
risk
practices
immunization
committee
advisory
increased
meningococcal
menacwycrm
months
recommendationsof
Embed Code Snippet
To get the embed code snippet please Login.
